The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity
Open accessAbstract
A defining feature of adaptive immunity is the development of long-lived memory T cells to curtail infection. Recent studies have identified a unique stem-like T-cell subset amongst exhausted CD8-positive T cells in chronic infection1–3, but it remains unclear whether CD4-positive T-cell subsets with similar features exist in chronic inflammatory conditions. Amongst helper T cells, TH17 cells have prominent roles in autoimmunity and tissue inflammation and are characterized by inherent plasticity4–7, although how such plasticity is regulated is poorly understood. Here we demonstrate that TH17 cells in a mouse model of autoimmune disease are functionally and metabolically heterogeneous; they contain a subset with stemness-associated features but lower anabolic metabolism, and a reciprocal subset with higher metabolic activity that supports transdifferentiation into TH1-like cells. These two TH17-cell subsets are defined by selective expression of the transcription factors TCF-1 and T-bet, and by discrete levels of CD27 expression. We also identify signalling via the kinase complex mTORC1 as a central regulator of TH17-cell fate decisions by coordinating metabolic and transcriptional programmes. TH17 cells with disrupted mTORC1 signalling or anabolic metabolism fail to induce autoimmune neuroinflammation or to develop into TH1-like cells, but instead upregulate TCF-1 expression and acquire stemness-associated features. Single-cell RNA sequencing and experimental validation reveal heterogeneity in fate-mapped TH17 cells, and a developmental arrest in the TH1 transdifferentiation trajectory upon loss of mTORC1 activity or metabolic perturbation. Our results establish that the dichotomy of stemness and effector function underlies the heterogeneous TH17 responses and autoimmune pathogenesis, and point to previously unappreciated metabolic control of plasticity in helper T cells. Phenotypically, transcriptionally and metabolically diverse subsets of TH17 cells develop in a chronic autoimmune disease: one subset has inferred stemness features and low anabolic metabolism, while a reciprocal subset has higher metabolic activity that supports transdifferentiation into TH1 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the non-pathogenic/homeostatic and pathogenic Th17 cell phenotypes studied in the mouse models may mirror the physiological roles of human Th17 cell subsets that are important for immunity against distinct bacteria and fungi”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458 · cited 1×
“1) or by fitting a linear model implemented in the R package “limma” 30 .”
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
MEME SUITE: tools for motif discovery and searching
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., & Noble, W. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp335 · Cited by 10,648
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110 · cited 3×
“The Cell Ranger 1.3 Single-Cell Software Suite (10× Genomics) was implemented to process the raw sequencing data from the Illumina HiSeq run.”
InfluentialBuenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422 · cited 3×
“After adjustment of Tn5 shift (reads were offset by +4 bp for the sense strand and −5 bp for the antisense strand), we separated reads into nucleosome-free, mononucleosome, dinucleosome, and trinucleosome as described in Buenrostro et al. 15 by fragment size and generated bigwig files by using the center 80 bp of frag…”
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 229
Engel, J. A., Lee, H. J., Williams, C. G., Kuns, R. D., Olver, S. D., Lansink, L. I. M., Soon, M. S. F., Andersen, S. B., Powell, J. E., Svensson, V., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137990 · Cited by 20
New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy
Oberholtzer, N. P., Quinn, K. M., Chakraborty, P., & Mehrotra, S. (2022) · Cells · doi:10.3390/cells11040708 · Cited by 19
“This study showed that Th17 cells in a mouse model of autoimmune disease are functionally and metabolically heterogeneous [101].”
BackgroundInfluentialSun, D., Li, W., Ding, D., Tan, K., Ding, W., Wang, Z., Fu, S., Hou, G., Zhou, W., & Gu, F. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01995-4 · Cited by 20
T cell plasticity in renal autoimmune disease
Soukou, S., Huber, S., & Krebs, C. F. (2021) · Cell and Tissue Research · doi:10.1007/s00441-021-03466-z · Cited by 19
Pan, Q., Ding, L., Hladyshau, S., Yao, X., Zhou, J., Yan, L., Dhungana, Y., Shi, H., Qian, C., Dong, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59620-6 · Cited by 24
Self-citationClemmensen, H. S., Dubé, J.-Y., McIntosh, F. A., Rosenkrands, I., Jungersen, G., Aagaard, C., Andersen, P. L., Behr, M. A., & Mortensen, R. J. (2021) · mBio · doi:10.1128/mbio.00226-21 · Cited by 19
DGK α and ζ Activities Control TH1 and TH17 Cell Differentiation
Yang, J., Wang, H., Xie, J., Li, L., Wang, J., Wan, E. C. K., & Zhong, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03048 · Cited by 19
Stem-like and effector peripheral helper T cells comprise distinct subsets in rheumatoid arthritis
Masuo, Y., Murakami, A., Akamine, R., Iri, O., Uno, S., Murata, K., Nishitani, K., Ito, H., Watanabe, R., Fujii, T., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adt3955 · Cited by 17
Fate-mapping mice: new tools and technology for immune discovery
Lee, S. E., Rudd, B. D., & Smith, N. L. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.01.004 · Cited by 15
Shimba, A., Cui, G., Abe, S., Hirota, K., Miyauchi, E., Takami, D., Tani-ichi, S., Kato, R., Tajima, M., Kanahashi, T., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116093 · Cited by 15
Shen, L., Che, L., He, Z., Lü, Q., Chen, D., Qin, Z., & Wang, B. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05736-w · Cited by 15
Zhang, G., Li, Y., & Wei, G. (2023) · Communications Biology · doi:10.1038/s42003-023-05141-1 · Cited by 16
“One outstanding study points out that metabolic heterogeneity underlies Th17 cell stemness and plasticity 55 .”
mTOR Is Key to T Cell Transdifferentiation
Yan, J., Wang, R., & Horng, T. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.008 · Cited by 15
“Declaration of Interests The authors declare no competing interests uthor M anuscript A uthor M anuscript A uthor M anuscript Karmaus et al (Karmaus et al., 2018) now demonstrate that in MOG-induced EAE, metabolic heterogeneity within the TH17 T cell population influences functional heterogeneity to impact lineage pla…”
BackgroundInfluentialDing, Y., Luo, H., & Qi, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1684-0 · Cited by 15
TH17 cell: a double-edged sword in the development of inflammatory bowel disease
Wen, Y., Wang, H., Tian, D., & Wang, G. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241230896 · Cited by 16
Tan, B., Malu, S., & Roth, K. D. W. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122120 · Cited by 14
Тодосенко, Н. М., Vulf, M. A., Yurova, K. A., Хазиахматова, О. Г., Mikhailova, L. V., & Litvinova, L. S. (2021) · Biomedicines · doi:10.3390/biomedicines9121750 · Cited by 14
“17 cells (with a pathogenic phenotype) [63].”
PD-1 limits differentiation and plasticity of Tc17 cells
Arra, A., Lingel, H., Pierau, M., & Brunner-Weinzierl, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104730 · Cited by 12
“CD27 + IL-17-producing T-cells have been shown to exhibit higher expression levels of TCF1, and indeed IL-17-producing T-cells encompassing CD27 + TCF1 hi subset have been inferred with stemness-associated features (53).”
CD147 Expressed on Memory CD4+ T Cells Limits Th17 Responses in Patients With Rheumatoid Arthritis
Miao, J., Zhang, K., Zheng, Z., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.545980 · Cited by 14
Ramos, J. M. P., Castellani, G., Kviatcovsky, D., Croese, T., Tsitsou-Kampeli, A., Burgaletto, C., Abellanas, M. A., Cahalon, L., Colaiuta, S. P., Salame, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58494-y · Cited by 18
“Other fi ndings suggested T H 17 cell-intrinsic metabolic pathways 19 – 21 , such as those involving nicotinamide adenine dinucleotide (NAD + ) and its related consuming-ectoenzyme CD38, as selective therapeutic targets for T cell metabolic rewiring 22 .”
The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension
Moshfegh, C. M., & Case, A. J. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8042 · Cited by 13
“For example, through genetic modification of mTOR signaling, mice showed inhibited ability of TH17 lymphocytes to transdifferentiate into TH1-like cells (72).”
BackgroundLyadova, I. V., & Nikitina, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00972 · Cited by 13
“In a mouse model of autoimmune disease, Th17 comprised two subsets, CD27 stemness-associated and CD27/T-bet able to transdifferentiate into Th1-like cells (163).”
BackgroundLooking Beyond Th17 Cells: A Role for Th17.1 Cells in Thyroid-associated Ophthalmopathy?
Jiang, M., Fu, Y., Wang, P., Yan, Y., Zhao, J., Wang, Y., & Yan, S. (2023) · Endocrinology · doi:10.1210/endocr/bqad004 · Cited by 12
Li, M., Wei, Y., Huang, W., Wang, C., He, S., Bi, S., Hu, S., You, L., & Huang, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-70498-0 · Cited by 14
Polyamine: A metabolic compass for T helper cell fate direction
Shi, H., & Chi, H. (2021) · Cell · doi:10.1016/j.cell.2021.07.012 · Cited by 12
Self-citationDevelopment of a 3D-Printed Ionization Source for Single-Cell Analysis
Liu, Q., Martínez‐Jarquín, S., Ge, W., et al. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04279 · Cited by 12
Alterations in Lymphocytic Metabolism—An Emerging Hallmark of MS Pathophysiology?
Greeck, V. B., Williams, S. K., Haas, J., Wildemann, B., & Fairless, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032094 · Cited by 14
“Another study employing 2-DG also reported it to protect mice from EAE through reducing CNS inflammation, as well as reporting a reduction in T cell infiltration and IFNγ release without affecting IL-17 levels [97].”
BackgroundInfluentialLee, S., Lee, K., Bae, H., Lee, K., Lee, J., Ma, J., Lee, Y. J., Lee, B. R., Park, W., & Im, S. J. (2023) · Nature Communications · doi:10.1038/s41467-023-41357-9 · Cited by 14
Zhao, Z., Huo, Y., Du, Y., Huang, Y., Liu, H., Zhang, C.-T., & Yan, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-52922-7 · Cited by 10
Leikeim, L., Li, H. Z., An, L., Sticht, C., Krämer, B. K., Yard, B. A., Leipe, J., & Kälsch, A. (2022) · Immunology · doi:10.1111/imm.13608 · Cited by 11
“Finally, findings on novel roles for Th cell subsets, including characterization of non- or anti-inflammatory Th17 cells with distinct metabolic requirements [44] and features shared with Treg, such as the ability to produce adenosine [9, 45–48], indicate the need for additional evaluation of Th17 cells as pro- or ant…”
BackgroundInfluentialRegulation of Autoreactive CD4 T Cells by FoxO1 Signaling in CNS Autoimmunity
Kraus, E. E., Kakuk‐Atkins, L., Farinas, M. F., Jeffers, M., Lovett‐Racke, A. E., & Yang, Y. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577675 · Cited by 13
Zhou, Q., Tao, C., Ge, Y., Yuan, J., Pan, F., Lin, X., & Wang, R. (2024) · BMC Biology · doi:10.1186/s12915-024-01931-z · Cited by 12
“The Monocle2 algorithm was utilized for conducting developmental trajectory analysis using genes with high dispersion and expression levels (dispersion estimate ≥ 1 and mean expression ≥ 0.1) [40, 41].”
MethodInfluentialYu, J., Xu, H., Cui, J., Chen, S., Zhang, H., Zou, Y., Zhao, J., Le, S., Jiang, L., Chen, Z., et al. (2020) · Aging · doi:10.18632/aging.103330 · Cited by 11
“In addition to providing cellular energy, glycometabolism also regulates cell differentiation [11, 12].”
BackgroundBao, K., Cui, Z., Wang, H., Xiao, H., Li, T., Kong, X., & Liu, T. (2021) · Phenomics · doi:10.1007/s43657-021-00024-z · Cited by 10
Unlocking the Role of Exercise on CD4+ T Cell Plasticity
Goldsmith, C., Donovan, T., Vlahovich, N., & Pyne, D. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.729366 · Cited by 12
“Briefly, Th17 cells are considered highly plastic, with fate mapping studies indicating they can give rise to Th1 cells (17) as well as intermediate phenotypic cells implicated in disease (18).”
BackgroundCytokine and metabolic regulation of adipose tissue Tregs
Elkins, C. M., & Li, C. (2022) · Immunometabolism · doi:10.1097/in9.0000000000000013 · Cited by 10
Bcl-3 regulates the function of Th17 cells through raptor mediated glycolysis metabolism
Liu, H., Zeng, L., Yang, Y., Huang, Z. D., Guo, C., Huang, L., Niu, X., Zhang, C., & Wang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.929785 · Cited by 10
“Deletion of raptor in Th17 cells leads to the defect of T-bet expression, resulting in reduced number of IL-17-IFN-g cells and reduced the inflammation and clinical manifestations of central nervous system in EAE model (26).”
BackgroundAgalioti, T., Cortesi, F., & Gagliani, N. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102333 · Cited by 8
Parween, F., Singh, S. P., Kathuria, N., Zhang, H. H., Ashida, S., Otaizo-Carrasquero, F. A., Shamsaddini, A., Gardina, P. J., Ganesan, S., Kabát, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57002-6 · Cited by 13
“…from the cerebrospinal fl uid (CSF) of study participants with multiple sclerosis (MS) and non-MS control participants, since a mouse model of MS, EAE, is the paradigmatic model in which pathogenic type 17 cells have been characterized 19,21,22 - and similar cells have been implicated in the Fig.”
InfluentialEngineered Th17 Cell Differentiation Using a Photoactivatable Immune Modulator
Parasar, B., & Chang, P. V. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c07485 · Cited by 9
Cheng, Z., Lu, J., Chen, Y., Cao, W., & Shao, Q. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113835 · Cited by 7
Deng, J., Deng, Y., Chen, Y., Bai, F., Zhang, B., Jiang, W., Wang, W., & Yu, H. (2025) · Medicinal Research Reviews · doi:10.1002/med.70024 · Cited by 7
Research progress on tumor-infiltrating lymphocyte therapy for cervical cancer
Zhang, W., Liu, Y., Li, D., Liu, S., Cai, X., Tang, J.-Y., Zuo, Z., Li, X., & Zhao, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1524842 · Cited by 9
“Th17 cells secrete IL-17, IL-22, and other cytokines, activate immune cells and enhance anti-tumor effects (25).”
Arsenio, J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0802-9_1 · Cited by 7
Durable CD4+ T cell immunity: cherchez la stem
Hughes, E. P., Syage, A. R., & Tantin, D. R. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.01.004 · Cited by 7
A GITRL‐mTORC1‐GM‐CSF Positive Loop Promotes Pathogenic Th17 Response in Primary Sjögren Syndrome
Gan, Y., Zhou, H., Guo, Y., Huang, B., Liu, H., Wang, Z., Li, Z., Zhao, X., Zhu, H., Han, Q., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42859 · Cited by 6
Zhan, L., Luo, S., Wang, H., Wang, J., Pan, X., Lin, Y. H., Jin, B., Liang, Y., & Chen, P. (2024) · Inflammation · doi:10.1007/s10753-024-02191-3 · Cited by 6
“Studies in other systems have demonstrated that key cytokines produced by macrophages, including IL-1β, IL-6, IL-23, and tumor necrosis factor alpha (TNF-α), create a cytokine milieu that regulates the expansion of human Th17 cells [21–23].”
Norton, E. G., Chapman, N. M., Shi, H., Meng, X., Huang, H., Anil, K. C., Rankin, S. L., Saravia, J., Yuan, S., Hu, H., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003074 · Cited by 6
Self-citationWørzner, K., Zimmermann, J., Buhl, R., Desoi, A., Christensen, D., Dietrich, J., Nguyen, N. D. N. T., Lindenstrøm, T., Woodworth, J. S., Alhakeem, R. S., et al. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103174 · Cited by 6
“We next asked whether CAF16 eliminates the Th17 cells or induces transdifferentiation into a non-IL-17A-expressing “ exTh17 ” cell subset, as has previously been described in the context of infectious or autoimmune diseases [4 – 6 , 9 ].”
BackgroundTian, Y., Sun, M., Luo, L., Lou, F., Zhou, P., Chen, J., Lv, H., Zhang, F., Zhang, M., & Wang, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-13322-7 · Cited by 5
Contextualizing TH17 cells in cancer
Pang, D., Bertocchi, A., Powrie, F. M., & Pohin, M. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-025-01250-6 · Cited by 7
Restricting SLC7A5-mediated Leucine uptake in T cells prevents acute GVHD and maintains GVT response
Fernández‐Gallego, N., Anega, B., Luengo-Arias, S., Bizkarguenaga, M., Gil‐Redondo, R., Embade, N., Navarrete-Arias, L., Ramírez‐Huesca, M., Álvarez-Corrales, E., Dosil, S. G., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00250-2 · Cited by 5
Uncovering New Challenges in Targeting Glycolysis to Treat Th17 Cell-Mediated Autoimmunity
Mosure, S. A., & Solt, L. A. (2021) · Immunometabolism · doi:10.20900/immunometab20210006 · Cited by 5
“Driven by key regulators of aerobic glycolysis, including mTORC, pathogenic Th17 cells exhibit increased glycolysis, which may drive inflammation by facilitating elevated protein, lipid, and nucleic acid synthesis necessary for increased proliferation and pro-inflammatory cytokine production [11,12].”
BackgroundDing, L., Shi, H., Qian, C., Burdyshaw, C., Veloso, J. P., Khatamian, A., Pan, Q., Dhungana, Y., Xie, Z., Risch, I., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.26.523391 · Cited by 5
Self-citationYuan, Y., Tian, Y., Zhao, Z., Yang, G., Wang, J., Zhu, F., Xue, G., Gao, F., Liu, Y., & Fan, H. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157441 · Cited by 6
High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustion
de Menezes, M. N., Chen, A. X. Y., Kulkarni, N., Sampurno, S., Saw, N. Y. L., Yap, K. M., Pérez-Núñez, I., Roth, S., Deguit, C., Haugen, B., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69671-y · Cited by 7
Application of single cell methods in immunometabolism and immunotoxicology
Karmaus, P. W. F. (2024) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2024.100488 · Cited by 4
Self-citationThe multifaceted roles of TCF1 in innate and adaptive lymphocytes
McCullen, M. V. D., & Oltz, E. M. (2024) · Advances in immunology · doi:10.1016/bs.ai.2024.10.001 · Cited by 4
Characterization and prognostic of CD8 + TIM3 + CD101 + T cells in glioblastoma multiforme
Wang, H., Li, S., Ma, C., Zheng, X.-H., Wu, H., Chang, C.-X., Yang, Z., Wang, J., Pan, F., & Zhao, B. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01390-1 · Cited by 4
Ca2+ Signaling Augmented by ORAI1 Trafficking Regulates the Pathogenic State of Effector T Cells
Wu, B., Woo, J. S., Sun, Z., Srikanth, S., & Gwack, Y. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100871 · Cited by 4
The Ketogenic Diet: An Anti-Inflammatory Treatment for Schizophrenia?
Hung, A., Krycer, J. R., Sarnyai, Z., Palmer, C., & Navarro, S. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s540859 · Cited by 3
“49 The key enzyme in de novo FAS, acetyl-CoA carboxylase 1 (ACC1), catalyzes the conversion of acetyl-CoA into malonyl-CoA, and elevated ACC1 expression enhances Th17 cell polarization by promoting retinoic acid-related orphan receptor gamma t (RORγt) binding to the IL-17 gene locus.”
He, S., Ma, F., Yu, M., Wu, J., Gong, Y.-M., Luo, K.-W., Chang, H. H., Qi, L., & Ning, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1707497 · Cited by 3
Single-cell atlas of hepatic cellular plasticity and immune niche reprogramming in liver cirrhosis
Zhang, Q., Zhou, N., Kan, X., Zhang, Z., Fang, Y., Liu, H., & Chen, Y. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07858-z · Cited by 3
“Pseudotime trajectories were constructed using highly dispersed and expressed genes (with a dispersion estimate ≥ 1 and average expression ≥ 0.1) [27].”
InfluentialTargeting abatacept-resistant T-helper-17 cells by aldehyde dehydrogenase inhibition
Tokifuji, Y., Hayabuchi, H., Sasaki, T., Hara‐Chikuma, M., Hirota, K., Takahashi, H., Amagai, M., Yoshimura, A., & Chikuma, S. (2023) · iScience · doi:10.1016/j.isci.2023.108646 · Cited by 3
“Regarding the mechanisms underlying the persistence of Th17 cells, Muranski et al. 8 have suggested the possibility of stemness, whereas Karmaus et al. 7 have proposed the existence of two metabolically distinct populations.”
BackgroundSzopa, I. M., Majchrzak, K., Pingwara, R., Kulka, M., Granica, M., & Gajewska, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104946 · Cited by 4
“Overall, heterogeneous subsets of T cells present differences in metabolic commitment, even within classically defined populations [83].”
Parween, F., Singh, S. P., Zhang, H. H., Kathuria, N., Otaizo-Carrasquero, F. A., Shamsaddini, A., Gardina, P. J., Ganesan, S., Kabát, J., Lorenzi, H., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.25.525561 · Cited by 3
“In mouse models these cells mediate pathology in experimental autoimmune encephalomyelitis (EAE) 31 , autoimmune colitis 36 and arthritis 38 .”
InfluentialWang, Z., Lai, L., Ran, S., Li, Y., Zhao, J., Wu, J., Guo, C., Cui, J., & Xia, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07383-5 · Cited by 4
“T SL cells recognize donor-derived peptide-MHC complexes via their TCRs and undergo repeated activation and differentiation into pro-inflammatory Th1, Th17, and cytotoxic CD8 + T cells [146].”
Zhang, G., Wu, Y., Qi, D., Zhou, J. J., Wu, X., Du, J., Xu, R., & Du, X. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07662-1 · Cited by 5
“For the cell lineage trajectory analysis of the CD8 + T-cell subsets, we sorted the cells in pseudotime order by selecting genes that met the thresholds of mean_expression ≥ 0.1 and dispersion_empirical ≥ 1, as identified by Monocle2 [30].”
InfluentialTh17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta
Chhabra, S., Sahu, S., Sharma, K., Sharma, M., Rani, L., Minz, R. W., & Dogra, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102633 · Cited by 2
Zhu, X., Zhang, J., Zhang, Z., Yuan, H., Xie, A., Zhang, N., Wang, M., Jiang, M., Xiao, Y., Wang, H., et al. (2023) · Current Bioinformatics · doi:10.2174/0115748936268168231114103440 · Cited by 2
Ubiquitination in the T Cell Metabolism-Based Immunotherapy in Diseases
Fan, K.-Q., Li, Y., & Jin, J. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-7288-9_2 · Cited by 2
Hero or villain? The heterogeneity of Th17 cells
Zhang, S. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.06.014 · Cited by 2
Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy
Sheppard, A. D., & Lysaght, J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0802-9_17 · Cited by 2
Voss, K., Young, A., Gibson-Corley, K. N., Sewell, A. E., Krystofiak, E., Bashum, J. H., Beavers, W. N., Sugiura, A., Skaar, E. P., Ormseth, M. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.25.470053 · Cited by 2
Flotillin-2 dampens T cell antigen sensitivity and functionality
Moon, S., Zhao, F., Uddin, M. N., Tucker, C. J., Karmaus, P. W. F., & Fessler, M. B. (2024) · JCI Insight · doi:10.1172/jci.insight.182328 · Cited by 1
“…lethally irradiated TCR α -deficient ( TCR α –/– ) recipient mice with a 1:5 ratio mixture of bone marrow cells from either Flot2 +/+ or Flot2 –/– donor mice and TCR α –/– mice, thereby generating mice with predominantly WT hematopoietic cells, except for a Flot2-deficient T cell compartment (34).”
Self-citationRole of CD28+ PD-1+ Tc cells in immune response and prognosis prediction in hepatocellular carcinoma
Yang, W., Pan, T., Chen, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1576193 · Cited by 1
“Trajectories were constructed using genes exhibiting both high expression and signi fi cant variability (dispersions ≥ 1 and average expressions ≥ 0.1) (19).”
InfluentialBrown, R. A., Dangel, A. W., Saini, A., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag110 · Cited by 1
Papadopoulou, G., Valakos, D., Polydouri, I., Moulara, A., Vatsellas, G., Angiari, S., Runtsch, M. C., Foretz, M., Viollet, B., Cassotta, A., et al. (2025) · Science Signaling · doi:10.1126/scisignal.adr3177 · Cited by 1
Wang, L., Zhang, R., Wang, L., Wang, Y., Zhang, X., & Zhou, G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334230 · Cited by 1
Multi-omics and perturbation screens as discovery tools in immunometabolism
Chapman, N. M., & Chi, H. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003570 · Cited by 1
“The concept of metabolic heterogeneity (or heterogenous metabolic states) underlying T cell function has also recently been introduced [1,5].”
Self-citationMetabolic adaptation in CD4+ T cells promotes immunosuppression in sepsis
Chapman, N. M., & Chi, H. (2026) · Nature Immunology · doi:10.1038/s41590-025-02403-4 · Cited by 1
Self-citationGuo, J., Zhu, Z., Tong, N., Xu, D., Zhang, H., Lin, C., Wan, G., Wang, Y., Zhou, Q., & Xia, L. (2026) · Discover Oncology · doi:10.1007/s12672-026-05166-y · Cited by 1
“Trajectories were constructed using genes exhibiting high dispersion (dispersion estimate ≥ 1) and adequate expression levels (average expression ≥ 0.1) [26].”
InfluentialZhang, P., Xu, C., Xu, L., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s539379 · Cited by 1
Liu, C., Xiong, F., Wang, L., Chen, K., Wu, P.-S., Hua, L., & Zhang, Z. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.533
TH17 cell: a double-edged sword in the development of inflammatory bowel diseasePreprint
Wang, G., Wen, Y., Wang, H., & Tian, D. (2024) · doi:10.22541/au.170663786.60739582/v1 · Cited by 1
Liang, S., Wang, X., Zhang, X., Wahyudi, A. H., Ma, W., Chen, L., Ding, L., & Chen, B. (2024) · Preprints.org · doi:10.20944/preprints202406.0930.v1 · Cited by 1
Yu, X., Wang, L., Yao, C., Qiu, R., Cui, Y., Dai, D., Deng, J., Hou, G.-J., Wang, Y., Qian, J., et al. (2017) · bioRxiv · doi:10.1101/218545
T Cells in The Regulation of Bone Metabolism
Komatsu, N., & Takayanagi, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62227-4
Chan, J. Y. H. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737501036.793584417
Faculty Opinions recommendation of Signaling networks in immunometabolism.
Kane, L. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737610223.793578145
Yi, L., Ma, Y., Liang, X., Linghu, L., & Zheng, G. (2023) · Research Square · doi:10.21203/rs.3.rs-2352106/v1
Röder, M., & Kahlfuß, S. (2022) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2022/4.1243
Hippo Signaling Regulates High-NaCl-Induced Increase in RORγt+ Pro-Inflammatory Lymphocytes
Zeeb, B. L., Weber‐Stiehl, S., Escudero‐Hernández, C., Müller, D. N., Maifeld, A., Sommer, F., Schmitt, R., & Sievers, L. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052143
“The capacity to integrate different signals renders Hippo signaling an ideal pathway to harmonize effects (e.g., cytokine activation and the surrounding micro milieu with NaCl content, oxygen, and mechanical stiffness), which in turn might contribute to Th17 lymphocyte heterogeneity [16].”
RNA‑seq analysis of predictive markers associated with glutamine metabolism in thyroid cancer
You, Y., Zhou, Y., Chen, Z., Deng, L., Shen, Y., Wang, Q., Long, W., Xiong, Y., Tan, F., Du, H., et al. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13510
Zhao, D., Zang, Z., Li, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-98663-z
“Pseudotime trajectories were constructed by using highly variable and highly expressed genes (discrete estimate ≥ 1 and average expression ≥ 0.1) 15 .”
InfluentialYu, Q., Ding, X., Xu, C., Zhu, L., & Lou, Y. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110514
Schnell, A., Burkett, P. R., Lee, Y., Peters, A., & Kuchroo, V. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00274-x
Immunometabolism Governs T Cell Immunity
Raynor, J. L., Shi, H., & Chi, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00275-1
Self-citationProgenitor T cells drive chronic pulmonary type 2 inflammation
Kratchmarov, R., Jia, X., Nagai, J., Pacheco, G. A., Perniss, A., Bell, M. A., Gül, E., Thompson, T. W., Hayashi, H., Saghaei, S., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02619-y
Tsai, S. J., Kapnick, S. M., Carey, S. T., McIlvaine, R. A., Rui, Y., Eppler, H. B., Shah, S., Bridgeman, C. J., Yanes, A. A., Black, S. K., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.10.026
Metadata
- Authors
- Karmaus, P. W. F., Chen, X., Lim, S. A., Herrada, A. A., Nguyen, T.-L. M., Xu, B., Dhungana, Y., Rankin, S., Chen, W., Rosencrance, C., Yang, K., Fan, Y., Cheng, Y., Easton, J., Neale, G., Vogel, P., & Chi, H.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Chi, Hongbo
- ORCID
- Venue
- Nature
- Published
- 2018-12-19
- Volume
- 565
- Issue
- 7737
- Pages
- 101-105
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6420879
- OpenAlex
- W2905426112
- Semantic Scholar
- ebe01d7ca54b23c200f359ee77ec3f9d963ffe99
- Cited by
- 215
- References
- 42
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 37 · 2023: 24 · 2022: 21 · 2021: 32 · 2020: 35 · 2019: 17
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- St. Jude Children's Research Hospital
- National Institutes of Health
- National Cancer Institute (R01CA176624, R01CA221290, P30CA021765)
- National Institute of Allergy and Infectious Diseases (R01AI101407, R01AI105887, R01AI140761, R01AI131703, R37AI105887)
- National Institute of Neurological Disorders and Stroke (R01NS064599)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- Th17 cells, T cell stemness, T cell plasticity, mTORC1 signaling, TCF1, T-bet, CD27, anabolic metabolism, autoimmune neuroinflammation, chronic autoimmune disease, single-cell RNA sequencing
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Regulatory-Associated Protein of mTOR, T-bet Transcription Factor, Animals, Autoimmune Diseases, Disease Models, Animal, Female, Immunologic Memory, Inflammation, Male, Stem Cells, Signal Transduction, Sequence Analysis, RNA, Tumor Necrosis Factor Receptor Superfamily, Member 7, T-Box Domain Proteins, Mice, T Cell Transcription Factor 1, Cell Transdifferentiation, Th17 Cells, Single-Cell Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review